Filing Details

Accession Number:
0001179110-19-011271
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-29 20:57:54
Reporting Period:
2019-10-25
Accepted Time:
2019-10-29 20:57:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1755098 Michelle Robertson C/O Momenta Pharmaceuticals, Inc.
301 Binney Street
Cambridge MA 02142
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-10-25 6,802 $15.00 6,813 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.